Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Johnson & Johnson

Request full access

Medicines and medical devices for patient care

New Brunswick, United StatesFounded 1886Health

About Johnson & Johnson

Johnson & Johnson (J&J) is a global healthcare company that operates in three main segments: pharmaceuticals, medical devices, and consumer health products. The company serves a wide range of clients, including individual consumers, healthcare professionals, and large healthcare institutions. J&J operates in the healthcare market, which is characterized by high demand for innovative medical solutions and products that improve patient outcomes.

The business model of Johnson & Johnson is diversified across its three segments. In the pharmaceuticals segment, J&J develops and markets prescription drugs that address various medical conditions, including cancer, immunology, and infectious diseases. The medical devices segment offers a broad range of products used in surgery, orthopedics, and vision care. The consumer health segment provides over-the-counter products, baby care, skin and hair care, wound care, and other personal health products.

Johnson & Johnson makes money by selling its products to consumers, healthcare providers, and institutions. Revenue is generated through direct sales, partnerships, and distribution agreements. The company invests heavily in research and development to innovate and bring new products to market, ensuring a steady pipeline of offerings that meet the evolving needs of its clients.

J&J is also known for its commitment to diversity, equity, and inclusion, creating a workplace where employees feel empowered to share their unique perspectives. The company offers various career opportunities, including internships, co-ops, and leadership development programs, making it an attractive employer for both new graduates and experienced professionals.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 1978
Employees
134,851
Open positions
81
Dealroom signal
90.6/100
Industry
Health
Sector
Biotechnology, observatoire healthtech
Business model
Manufacturing
Client focus
B2B, B2C
Investment activity
100 companies, latest Aug 2026
Capital deployed
$3.2B
Preferred round
ACQUISITION

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPO✓Exit Jan 1978 $0 — Undisclosed —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Johnson & Johnson website traffic

Latest recorded traffic for Johnson & Johnson is 3.1M monthly website visits, up 55% over the last three months. Johnson & Johnson's team grew 30.6% over the past year.

Latest monthly visits3.1M 3-month web change+55% 1-year team growth+30.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Delix TherapeuticsBedford, United StatesApplying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics $275Mvaluation Firefly BioSouth San Francisco, United StatesUnlocking new classes of payloads to maximize the potential of ADCs $1Bvaluation Sail BiomedicinesUnited StatesProgrammable RNA medicines for in vivo CAR-T therapies. Atraverse MedicalChicago, United StatesAtraverse Medical develops left-heart access technology to simplify workflows and enhance patient outcomes $118Mvaluation Mestag TherapeuticsSaffron Walden, United KingdomDeveloping antibody therapeutics targeting fibroblast-immune interactions $160Mvaluation Halda TherapeuticsNew Haven, United StatesPrecision oncology therapies targeting cancer via RIPTAC™ chimera $3Bvaluation Cellular OriginsRoyston, United KingdomEnabling patient access to cell therapies for today and tomorrow $160Mvaluation OBarisSchlieren, SwitzerlandOur mission is to improve the life quality of patients depending on painful injectable drugs by offering them OBarisZurich, SwitzerlandDeveloping OctoPatch®, a painless patch for patients using injectable drugs Ruilongnuofu Medical TechnologyMinhang District, ChinaDeveloping MIS and digital surgery solutions $600Mvaluation SensoriDallas, United StatesAlcohol-free tonic with nootropics and adaptogens $4Mvaluation Intracellular TherapiesNew York City, United StatesTherapeutics for central nervous system disorders $377Mvaluation

Johnson & Johnson in the New Brunswick ecosystem

Live from Dealroom

The Johnson & Johnson office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors8 additional known investors

  • Aisling Capital
  • Apple Tree Partners
  • Ben Franklin Technology Partners of Southeastern Pennsylvania
  • InterWest Partners
  • NaviMed Capital
  • New Generation Industry Leaders | World Economic Forum
  • Project Liberty Digital Incubator
  • Prospect Venture Partners
Team profiled 2,835 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 20 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New Brunswick HQ
Book a demo for the full country breakdown

See Johnson & Johnson’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.